Видео ютуба по тегу Idh Mutation

IDH Mutations in Cancer
IDH Mutations in Cancer
History of Brain Tumor Classification and Discovery of the IDH Mutation | UCSF Brain Tumor Center
History of Brain Tumor Classification and Discovery of the IDH Mutation | UCSF Brain Tumor Center
The Patient is In: Introduction to IDH-mutant cancers with Matthew Vander Heiden
The Patient is In: Introduction to IDH-mutant cancers with Matthew Vander Heiden
IDH Mutations in AML
IDH Mutations in AML
NOW Program Educational Webinars: IDH-Mutant Gliomas (2023)
NOW Program Educational Webinars: IDH-Mutant Gliomas (2023)
From Mutation to Treatment: Understanding IDH Inhibitors
From Mutation to Treatment: Understanding IDH Inhibitors
IDH Inhibitors for Cholangiocarcinoma
IDH Inhibitors for Cholangiocarcinoma
Hope in Brain Cancer: The Story of Oligodendroglioma with IDH Mutation & 1p/19q Co Deletion
Hope in Brain Cancer: The Story of Oligodendroglioma with IDH Mutation & 1p/19q Co Deletion
IDH - Mutant Astrocytoma: Update from the 5th Edition WHO Classification of CNS Tumors
IDH - Mutant Astrocytoma: Update from the 5th Edition WHO Classification of CNS Tumors
Addressing treatment options for IDH-mutant gliomas
Addressing treatment options for IDH-mutant gliomas
Diffuse Astrocytoma IDH mutant - Adventures in Neuropathology
Diffuse Astrocytoma IDH mutant - Adventures in Neuropathology
The impact of IDH mutated clones in NPM1+ AML
The impact of IDH mutated clones in NPM1+ AML
The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigation
The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigation
How Does IDH Mutation Affect Oligodendroglioma Prognosis? - Brain Health Support Network
How Does IDH Mutation Affect Oligodendroglioma Prognosis? - Brain Health Support Network
IDH Mutations: Oncometabolite Deregulation of Epigenetic Remodeling
IDH Mutations: Oncometabolite Deregulation of Epigenetic Remodeling
How Do IDH Mutations Cause Tumors?
How Do IDH Mutations Cause Tumors?
ICRN Webinar:
ICRN Webinar: "What is IDH1 mutated cholangiocarcinoma and what else can we do for it?”
Highlights From the Annual Neuro-Oncology Conference: Redefining IDH-Mutant Glioma Management
Highlights From the Annual Neuro-Oncology Conference: Redefining IDH-Mutant Glioma Management
Early intervention with IDH inhibitors in IDH-mutated MDS: insights from clinical experience
Early intervention with IDH inhibitors in IDH-mutated MDS: insights from clinical experience
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: Julie Miller, MD, PhD
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: Julie Miller, MD, PhD